Nikko Asset Management Americas, Inc. - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 336 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nikko Asset Management Americas, Inc. ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$13,257,801
+9.1%
292,473
-1.2%
0.16%
+23.4%
Q2 2023$12,147,335
+23.5%
296,132
-0.4%
0.13%
+13.3%
Q1 2023$9,834,325
-22.6%
297,469
-11.7%
0.11%
-38.3%
Q4 2022$12,711,633
-20.5%
336,732
-23.0%
0.18%
-10.3%
Q3 2022$15,983,000
+3.5%
437,176
-6.6%
0.20%
+6.8%
Q2 2022$15,448,000
-28.1%
468,116
-21.9%
0.19%
+20.9%
Q1 2022$21,490,000
+19.8%
599,616
-1.0%
0.16%
+68.1%
Q4 2021$17,935,000
-20.7%
605,902
-10.3%
0.09%
-3.1%
Q3 2021$22,623,000
+11.0%
675,301
+32.8%
0.10%
+21.2%
Q2 2021$20,381,000
-9.0%
508,374
+2.0%
0.08%
-27.3%
Q1 2021$22,402,000
+22.6%
498,256
+54.2%
0.11%
+5.8%
Q4 2020$18,272,000
+70.0%
323,168
+41.9%
0.10%
+9.5%
Q3 2020$10,746,000
-24.7%
227,667
-7.8%
0.10%
-49.2%
Q2 2020$14,272,000
-60.4%
246,919
-67.6%
0.19%
-44.7%
Q1 2020$36,038,000
+40.5%
762,224
+79.5%
0.34%
-16.3%
Q4 2019$25,655,000
+17.6%
424,683
+16.6%
0.40%
+4.1%
Q3 2019$21,813,000
+10.2%
364,091
+18.2%
0.39%0.0%
Q2 2019$19,795,000
+35.8%
308,002
+71.6%
0.39%
+1.0%
Q1 2019$14,573,000179,5330.38%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Bellevue Group AG 9,930,245$396,117,0003.87%
Sicart Associates LLC 368,409$14,696,0003.50%
Camber Capital Management LP 2,000,000$79,780,0002.69%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 181,781$7,251,0001.91%
SECTOR GAMMA AS 263,488$10,511,0001.86%
Parkman Healthcare Partners LLC 136,380$5,440,0001.19%
Eversept Partners, LP 442,000$17,631,3801.18%
Affinity Asset Advisors, LLC 75,000$2,992,0001.07%
TANAKA CAPITAL MANAGEMENT INC 16,661$665,0000.90%
Sonora Investment Management, LLC 168,665$6,728,0000.88%
View complete list of IONIS PHARMACEUTICALS INC shareholders